Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune cell oxidative burst, also known as the respiratory burst, is a rapid physiological process characterized by the sudden increase in oxygen consumption and the subsequent release of reactive oxygen species (ROS) by phagocytes, such as neutrophils and macrophages (StatPearls, 2023). This process is primarily mediated by the Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) enzyme complex, specifically the NOX2 isoform, which transfers electrons from NADPH to molecular oxygen to generate superoxide anions (UniProt, P04839). While essential for the destruction of invading pathogens within the phagosome, excessive or inappropriate activation of the oxidative burst is a major driver of tissue injury in chronic inflammatory conditions, cardiovascular diseases, and neurodegeneration (PubMed, PMC2724613). Pharmacological inhibitors of the NADPH oxidase complex are being investigated to reduce oxidative damage in these contexts. However, because this process is vital for host defense, its inhibition carries a significant risk of immunosuppression, mimicking the clinical presentation of Chronic Granulomatous Disease, where patients suffer from life-threatening recurrent infections (NIH, GeneReviews).
Inhibition of the NADPH oxidase enzyme complex to prevent the production of superoxide anions and other reactive oxygen species.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) (NOX2).